Jennifer Siew Kee Lau

Title: Innovations by Jennifer Siew Kee Lau

Introduction

Jennifer Siew Kee Lau is a notable inventor based in Singapore, recognized for her contributions to the field of biotechnology. She has made significant strides in developing solutions that address critical challenges in the swine industry.

Latest Patents

Jennifer holds a patent for the "Production of homogeneous cell line highly permissive to porcine circovirus type 2 (PCV2) infection." This invention describes continuous cell lines that are highly permissive to infection by PCV2, which is the causal agent of post-weaning multi-systemic wasting syndrome (PMWS) in pigs. PMWS has emerged as a major disease that poses a significant threat to the economics of the global swine industry. The highly permissive cell lines of this invention provide efficient and reliable sources of PCV2 for use in the development of vaccines, therapies, and diagnostic agents for PMWS.

Career Highlights

Jennifer is currently associated with Temasek Life Sciences Laboratory Limited, where she continues to advance her research and innovations. Her work has been pivotal in enhancing the understanding and management of diseases affecting livestock.

Collaborations

Jennifer collaborates with esteemed colleagues, including Adeline Hui Ling Lau and Hwei-Sing Jimmy Kwang, contributing to a dynamic research environment that fosters innovation.

Conclusion

Jennifer Siew Kee Lau's work exemplifies the impact of innovative research in biotechnology, particularly in addressing significant challenges in the swine industry. Her contributions are vital for the development of effective solutions that benefit both the industry and public health.